标题
Complement in monoclonal antibody therapy of cancer
作者
关键词
Monoclonal antibody, CDC, ADCC, Complement, Cancer therapy
出版物
IMMUNOLOGIC RESEARCH
Volume 59, Issue 1-3, Pages 203-210
出版商
Springer Nature
发表日期
2014-06-06
DOI
10.1007/s12026-014-8542-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Within Peripheral Blood Mononuclear Cells, Antibody-Dependent Cellular Cytotoxicity of Rituximab-Opsonized Daudi cells Is Promoted by NK Cells and Inhibited by Monocytes due to Shaving
- (2014) P. V. Beum et al. JOURNAL OF IMMUNOLOGY
- Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models
- (2013) S. Herter et al. MOLECULAR CANCER THERAPEUTICS
- Complement factor H related proteins (CFHRs)
- (2013) Christine Skerka et al. MOLECULAR IMMUNOLOGY
- Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab
- (2013) Srinivas Mamidi et al. Molecular Oncology
- Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy
- (2013) Christel Devaud et al. MOLECULAR THERAPY
- Antibody Therapeutics in Cancer
- (2013) M. X. Sliwkowski et al. SCIENCE
- Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma
- (2012) Bridget Charbonneau et al. AMERICAN JOURNAL OF HEMATOLOGY
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Opposing Roles for Complement Component C5a in Tumor Progression and the Tumor Microenvironment
- (2012) L. Gunn et al. JOURNAL OF IMMUNOLOGY
- Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in
- (2012) V Goede et al. LEUKEMIA
- Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement
- (2012) Nisar A. Baig et al. LEUKEMIA & LYMPHOMA
- Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells
- (2012) Michael G Strainic et al. NATURE IMMUNOLOGY
- Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism
- (2011) S. Veeramani et al. BLOOD
- Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma
- (2011) Matthew J. Barth et al. BRITISH JOURNAL OF HAEMATOLOGY
- Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
- (2011) Toni M. Brand et al. CANCER BIOLOGY & THERAPY
- Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
- (2011) P. V. Beum et al. JOURNAL OF IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model
- (2009) S.-Y. Wang et al. BLOOD
- Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
- (2009) S. Heinen et al. BLOOD
- Resistance to Trastuzumab in Breast Cancer
- (2009) P. R. Pohlmann et al. CLINICAL CANCER RESEARCH
- C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells
- (2009) Donald J. Weaver et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The complement system in systemic autoimmune disease
- (2009) Min Chen et al. JOURNAL OF AUTOIMMUNITY
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Factor H and Factor H-Related Protein 1 Bind to Human Neutrophils via Complement Receptor 3, Mediate Attachment to Candida albicans, and Enhance Neutrophil Antimicrobial Activity
- (2009) J. Losse et al. JOURNAL OF IMMUNOLOGY
- Modulation of Protective T Cell Immunity by Complement Inhibitor Expression on Tumor Cells
- (2008) J. C. Varela et al. CANCER RESEARCH
- Development of Novel Tetravalent Anti-CD20 Antibodies with Potent Antitumor Activity
- (2008) B. Li et al. CANCER RESEARCH
- A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma
- (2008) E. Racila et al. CLINICAL CANCER RESEARCH
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More